Sara Comini
Overview
Explore the profile of Sara Comini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boattini M, Gaibani P, Comini S, Costa C, Cavallo R, Broccolo F, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Mar;
PMID: 40064744
The carbapenemase-producing Gram-negative organisms represent an urgent clinical and public health concern, as they have been associated with increased mortality and high dissemination in healthcare settings. Although overall incidence rates...
2.
Boattini M, Guarrasi L, Comini S, Ricciardelli G, Casale R, Cavallo R, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Jan;
PMID: 39838142
Purpose: To evaluate diagnostic performance of four diagnostic methods for rapid determination of methicillin resistance in S. aureus positive blood cultures (BCs). Methods: Clinical and spiked BCs were subjected to...
3.
Rezende F, da Silva D, Comini S, de Mendonca S, Santos E, Baldon L, et al.
Insects
. 2025 Jan;
15(12.
PMID: 39769580
Malaria continues to be a major public health challenge in tropical and subtropical regions. , a key laboratory model for malaria research, plays a critical role in the study of...
4.
Bianco G, Boattini M, Cricca M, Diella L, Gatti M, Rossi L, et al.
Curr Issues Mol Biol
. 2024 Dec;
46(12):14132-14153.
PMID: 39727974
In recent years, novel antimicrobials have been developed to counter the emergence of antimicrobial resistance and provide effective therapeutic options against multidrug-resistant (MDR) Gram-negative bacilli (GNB). Cefiderocol, a siderophore cephalosporin,...
5.
Bianco G, Boattini M, Lupo L, Ambretti S, Greco R, DeglInnocenti L, et al.
J Antimicrob Chemother
. 2024 Dec;
80(2):583-592.
PMID: 39699187
Objectives: To evaluate the in vitro activity of ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae (KPC-Kp) clinical isolates collected from a multicentre study in Italy (2022-23) and genomic...
6.
Boattini M, Bianco G, Comini S, Costa C, Gaibani P
Eur J Clin Microbiol Infect Dis
. 2024 Oct;
43(12):2407-2417.
PMID: 39384682
Introduction: Understanding the dynamics that may characterize the emergence of KPC variants with resistance to novel β-lactam/β-lactamase inhibitor combinations (βL/βLICs) represents a challenge to be overcome in the appropriate use...
7.
Bianco G, Boattini M, Comini S, Gibellini D, Gaibani P
Int J Antimicrob Agents
. 2024 Oct;
64(5):107343.
PMID: 39362613
No abstract available.
8.
Baldon L, de Mendonca S, Santos E, Marcal B, de Freitas A, Rezende F, et al.
Trop Med Infect Dis
. 2024 Sep;
9(9).
PMID: 39330890
West Nile Virus (WNV) poses a significant global public health threat as a mosquito-borne pathogen. While laboratory mouse models have historically played a crucial role in understanding virus biology, recent...
9.
Casale R, Boattini M, Comini S, Bastos P, Corcione S, De Rosa F, et al.
Infection
. 2024 Jul;
53(1):183-196.
PMID: 38990473
Introduction: Non-fermenting Gram-negative bacilli (NFGNB) other than Pseudomonas aeruginosa and Acinetobacter baumannii complex are pathogens of interest due to their ability to cause health-care associated infections and display complex drug...
10.
Bianco G, Boattini M, Comini S, Bondi A, Curtoni A, Piccinini G, et al.
J Antimicrob Chemother
. 2024 Jul;
79(9):2237-2245.
PMID: 38958300
Objectives: The measurement of VOCs release in the headspace of a bacterial culture represents a new approach to rapidly assess antimicrobial susceptibility. Herein, we evaluated the diagnostic performance of the...